TABLE 1.
Anthropometric and biochemical characteristics of the study population based on the chronic hepatitis B status.
| NAFLD (n = 37) | NAFLD + CHB (n = 18) | P | P1* | |
| Anthropometric characteristic | ||||
| Age, years | 34.30 ± 10.84 | 35.78 ± 9.65 | 0.625 | – |
| Male, n (%) | 30.00 (81.10) | 14.00 (77.8) | 0.779 | – |
| BMI, kg/m2 | 28.20 ± 3.33 | 27.35 ± 2.60 | 0.350 | – |
| Weight, kg | 80.86 ± 13.14 | 76.08 ± 8.18 | 0.164 | 0.192 |
| Height, cm | 170.00 (166.50, 175.0) | 167.50 (162.25, 170.25) | 0.102 | 0.283 |
| Waist circumference, cm | 96.63 ± 7.90 | 94.41 ± 5.52 | 0.292 | 0.572 |
| Hip circumference, cm | 103.43 ± 6.70 | 101.07 ± 5.76 | 0.205 | 0.423 |
| Waist/hip ratio | 0.93 ± 0.48 | 0.94 ± 0.05 | 0.942 | 0.888 |
| Neck circumference, cm | 40.01 ± 2.98 | 40.31 ± 2.70 | 0.719 | 0.167 |
| Biochemical characteristic | ||||
| SBP, mmHg | 126.12 ± 11.90 | 123.67 ± 15.91 | 0.524 | 0.209 |
| DBP, mmHg | 83.35 (73.00, 90.25) | 86.50 (69.00, 90.25) | 0.713 | 0.654 |
| ALT, U/L | 67.80 (33.20, 100.50) | 44.75 (25.28, 76.60) | 0.274 | 0.898 |
| AST, U/L | 31.90 (25.00, 47.35) | 24.95 (19.95, 32.55) | 0.136 | 0.893 |
| ALT/AST | 0.51 (0.41, 0.72) | 0.65 (0.48, 0.70) | 0.216 | 0.554 |
| TG, mmol/L | 1.81 (1.31, 2.65) | 1.64 (1.02, 2.21) | 0.524 | 0.630 |
| TC, mmol/L | 5.05 (4.51, 5.76) | 4.88 (4.48, 5.52) | 0.760 | 0.602 |
| HDL, mmol/L | 1.20 (1.05, 1.30) | 1.15 (0.97, 1.36) | 0.740 | 0.596 |
| LDL, mmol/L | 2.98 (2.52, 3.44) | 2.82 (2.56, 3.47) | 0.865 | 0.838 |
| APOA, g/L | 1.44 (1.26, 1.56) | 1.36 (1.29, 1.54) | 0.879 | 0.786 |
| APOB, g/L | 1.03 (0.86, 1.14) | 1.06 (0.92, 1.28) | 0.490 | 0.873 |
| Uric acid, μM | 418.61 ± 108.93 | 361.88 ± 105.75 | 0.073 | 0.104 |
| Glucose, mmol/L | 5.05 (4.73, 5.98) | 5.08 (4.73, 6.34) | 0.993 | 0.539 |
Data are expressed as means ± standard deviation (SD) or median (interquartile range) based on the variable distribution. *P1: P value was adjusted for age, sex, and body mass index. ALT, alanine aminotransferase; APOA, apolipoprotein A; APOB, apolipoprotein B; AST, aspartate aminotransferase; BMI, Body mass index; CHB, chronic hepatitis B; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NAFLD, non-alcoholic fatty liver disease; NAFLD + CHB, concurrent non-alcoholic fatty liver disease and chronic hepatitis B; SBP, systolic Blood Pressure; TC, total cholesterol; TG, triglyceride.